Welcome to our Startup Showcase, where we shine a spotlight on groundbreaking startups that are making waves in the European business landscape. Today, we present Protembis, a medical device startup that is transforming the landscape of Transcatheter Aortic Valve Replacement (TAVR) procedures with their revolutionary innovation, ProtEmbo. Based in Aachen, Nordrhein-Westfalen, Germany, Protembis is at the forefront of engineering and technology, delivering simple and reliable solutions to improve patient outcomes during TAVR procedures.
A Major Revolution in Heart Disease Care
The advent of transcatheter treatments for valvular heart disease has been a game-changer in medical care. Patients with disabilities or intercurrent illnesses, who were unable to undergo stressful open cardiac surgical procedures, found new hope through TAVR. However, despite ongoing advancements in TAVR procedures, there remained a significant concern – the occurrence of cerebrovascular events during the procedure.
ProtEmbo: Redefining Safety in TAVR
Enter Protembis, a visionary startup founded on the mission to reduce the risk of cerebrovascular events during TAVR procedures, ultimately making the process even safer for patients. With TAVR shifting towards younger and lower-risk patients, the need for enhanced safety measures becomes even more critical.
ProtEmbo System is the brainchild of Protembis, an adjunctive device used during TAVR to improve outcomes significantly. The system features an intra-aortic filter device, precisely designed to deflect embolic material that may arise during the procedure away from the cerebral circulation. This remarkable innovation is set to revolutionize the landscape of TAVR procedures and is expected to become a game-changer in the medical industry.
The Benefits of ProtEmbo
Undergoing TAVR procedures can be daunting for both patients and healthcare professionals. However, with the implementation of ProtEmbo, the fear of cerebrovascular events can be significantly reduced, providing a higher level of confidence and safety during the process. By mitigating the risk of embolic material reaching the cerebral circulation, Protembis is paving the way for better patient outcomes and smoother procedures.
The Vision and Impact
Protembis was founded on a clear vision – to enhance the safety and efficacy of TAVR procedures, thus improving patient outcomes. With ProtEmbo, they are set to achieve this vision, enabling healthcare professionals to perform TAVR procedures with greater confidence and peace of mind. Their dedication to innovation and patient well-being is bound to have a positive impact on the medical community and the lives of countless patients worldwide.
At EUStartup.news, we are committed to showcasing innovative startups that are making a difference in various industries. Protembis stands as a shining example of a company dedicated to transforming medical procedures for the betterment of patients’ lives. With ProtEmbo, they have created a reliable and groundbreaking solution that promises to redefine the landscape of TAVR procedures, ultimately making them even safer and more effective.
For more information about Protembis and their remarkable innovation, visit their website: Protembis Website
Stay connected with Protembis on their LinkedIn page: Protembis LinkedIn
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!